menu
    • menu

    Find Inclisiran manufacturers, exporters & distributors on PharmaCompass

    Evonik

    Virtual Booth

    Contact Supplier

    Fishfa Biogenics: Renowned Manufacturer, & Exporter of Tacrolimus & Mupirocin API.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass

    Synopsis

    Related ProductsRelated Products

    Synopsis

    ACTIVE PHARMA INGREDIENTS

    4

    API Suppliers

    API Suppliers

    0

    USDMF

    US DMFs Filed

    0

    CEP/COS

    CEP/COS Certifications

    0

    JDMF

    JDMFs Filed

    0

    EU WC

    EU WC

    0

    KDMF

    KDMF

    1

    NDC API

    NDC API

    0

    VMF

    NDC API

    4

    Listed Suppliers

    Other Suppliers

    API REF. PRICE (USD/KG)

    $
    $ 0

    MARKET PLACE

    3

    API

    0

    FDF

    0INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    6

    FDF Dossiers

    FDF Dossiers

    1

    FDA Orange Book

    FDA (Orange Book)

    2

    Europe

    Europe

    0

    Canada

    Canada

    3

    Australia

    Australia

    0

    South Africa

    South Africa

    0

    Listed Dossiers

    Listed Dossiers

    20DRUGS IN DEVELOPMENT

    FDF Dossiers

    DRUG PRODUCT COMPOSITIONS

    REF. STANDARDS OR IMPURITIES

    0

    EDQM

    0

    USP

    0

    JP

    0

    Others

    PATENTS & EXCLUSIVITIES

    13

    US Patents

    1

    US Exclusivities

    0

    Health Canada Patents

    DIGITAL CONTENT

    3

    Data Compilation #PharmaFlow

    0

    Stock Recap #PipelineProspector

    0

    Weekly News Recap #Phispers

    47

    News #PharmaBuzz

    GLOBAL SALES INFORMATION

    US Medicaid

    NA

    Annual Reports

    479

    Finished Drug Prices

    Listed Dossiers

    0RELATED EXCIPIENT COMPANIES

    0EXCIPIENTS BY APPLICATIONS

    Chemistry

    Click the arrow to open the dropdown
    read-moreClick the button for full data set
    read-moreClick the button for full data set

    API SUPPLIERS

    read-more
    read-more

    01

    EUROAPI

    France

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Bio-Europe 2024
    Exhibiting
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothEUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    EUROAPI Compnay Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Anhui Ribobay Pharmaceutical Co.,L...

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Bio-Europe 2024
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothRibobay has expertise in oligonucleotides from siRNA, Antisense Oligonucleotides, miRNAs, and aptamers & Oligonucleotides CXOs.

    Contact Supplier Contact Supplier
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    Ribobay-Company-Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Omgene Life Sciences Pvt. Ltd

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    CPhI India 2024
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothOmgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    Omgene Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Gyma Laboratories of America, Inc.

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    World Vaccine Congress
    Not Confirmed
    arrow

    Gyma Laboratories of America, Inc.

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    World Vaccine Congress
    Not Confirmed
    USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    DATA COMPILATION #PharmaFlow

    read-more
    read-more

    NEWS #PharmaBuzz

    read-more
    read-more

    Global Sales Information

    Do you need Business Intel? Ask us

    Market Place

    Do you need sourcing support? Ask us

    Patents & EXCLUSIVITIES

    Check the patents & exclusivity for this product

    US Patents

    read-more
    read-more

    01

    NOVARTIS

    INCLISIRAN SODIUM

    arrow
    SupplySide West 2024
    Not Confirmed

    NOVARTIS

    Switzerland
    arrow
    SupplySide West 2024
    Not Confirmed

    Patent Expiration Date : 2027-05-10

    INCLISIRAN SODIUM

    US Patent Number : 8809292

    Drug Substance Claim : Y

    Drug Product Claim : Y

    Application Number : 214012

    Patent Use Code : U-3652

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2027-05-10

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    NOVARTIS

    INCLISIRAN SODIUM

    arrow
    SupplySide West 2024
    Not Confirmed

    NOVARTIS

    Switzerland
    arrow
    SupplySide West 2024
    Not Confirmed

    Patent Expiration Date : 2027-12-29

    INCLISIRAN SODIUM

    US Patent Number : 8222222

    Drug Substance Claim :

    Drug Product Claim :

    Application Number : 214012

    Patent Use Code : U-3652

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2027-12-29

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    NOVARTIS

    INCLISIRAN SODIUM

    arrow
    SupplySide West 2024
    Not Confirmed

    NOVARTIS

    Switzerland
    arrow
    SupplySide West 2024
    Not Confirmed

    Patent Expiration Date : 2029-12-12

    INCLISIRAN SODIUM

    US Patent Number : 8106022

    Drug Substance Claim : Y

    Drug Product Claim : Y

    Application Number : 214012

    Patent Use Code : U-3652

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2029-12-12

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    NOVARTIS

    INCLISIRAN SODIUM

    arrow
    SupplySide West 2024
    Not Confirmed

    NOVARTIS

    Switzerland
    arrow
    SupplySide West 2024
    Not Confirmed

    Patent Expiration Date : 2036-08-25

    INCLISIRAN SODIUM

    US Patent Number : 10851377

    Drug Substance Claim :

    Drug Product Claim :

    Application Number : 214012

    Patent Use Code : U-3652

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2036-08-25

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    NOVARTIS

    INCLISIRAN SODIUM

    arrow
    SupplySide West 2024
    Not Confirmed

    NOVARTIS

    Switzerland
    arrow
    SupplySide West 2024
    Not Confirmed

    Patent Expiration Date : 2028-12-04

    INCLISIRAN SODIUM

    US Patent Number : 10806791

    Drug Substance Claim : Y

    Drug Product Claim :

    Application Number : 214012

    Patent Use Code :

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2028-12-04

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    NOVARTIS

    INCLISIRAN SODIUM

    arrow
    SupplySide West 2024
    Not Confirmed

    NOVARTIS

    Switzerland
    arrow
    SupplySide West 2024
    Not Confirmed

    Patent Expiration Date : 2028-08-24

    INCLISIRAN SODIUM

    US Patent Number : 10131907

    Drug Substance Claim : Y

    Drug Product Claim : Y

    Application Number : 214012

    Patent Use Code : U-3652

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2028-08-24

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    NOVARTIS

    INCLISIRAN SODIUM

    arrow
    SupplySide West 2024
    Not Confirmed

    NOVARTIS

    Switzerland
    arrow
    SupplySide West 2024
    Not Confirmed

    Patent Expiration Date : 2024-05-18

    INCLISIRAN SODIUM

    US Patent Number : 11530408

    Drug Substance Claim : Y

    Drug Product Claim :

    Application Number : 214012

    Patent Use Code :

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2024-05-18

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    NOVARTIS

    INCLISIRAN SODIUM

    arrow
    SupplySide West 2024
    Not Confirmed

    NOVARTIS

    Switzerland
    arrow
    SupplySide West 2024
    Not Confirmed

    Patent Expiration Date : 2034-08-18

    INCLISIRAN SODIUM

    US Patent Number : 10125369

    Drug Substance Claim : Y

    Drug Product Claim : Y

    Application Number : 214012

    Patent Use Code : U-3652

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2034-08-18

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    NOVARTIS

    INCLISIRAN SODIUM

    arrow
    SupplySide West 2024
    Not Confirmed

    NOVARTIS

    Switzerland
    arrow
    SupplySide West 2024
    Not Confirmed

    Patent Expiration Date : 2024-03-08

    INCLISIRAN SODIUM

    US Patent Number : 10669544

    Drug Substance Claim : Y

    Drug Product Claim :

    Application Number : 214012

    Patent Use Code :

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2024-03-08

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    NOVARTIS

    INCLISIRAN SODIUM

    arrow
    SupplySide West 2024
    Not Confirmed

    NOVARTIS

    Switzerland
    arrow
    SupplySide West 2024
    Not Confirmed

    Patent Expiration Date : 2028-12-04

    INCLISIRAN SODIUM

    US Patent Number : 8828956

    Drug Substance Claim : Y

    Drug Product Claim : Y

    Application Number : 214012

    Patent Use Code : U-3652

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2028-12-04

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search